Day: September 25, 2020

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., senior vice president of translational research, will present at the Stifel Immunology and Inflammation Virtual Summit. Dr. Blouse will speak on a panel entitled: “The evolution of complement targeted therapies,” taking place on Thursday, October 1, 2020, at 9:00 AM Eastern Time.To access a live webcast of the panel presentation, please click here.An archived webcast of the presentation will be available for 90 days on the Events and Presentations section on the Company’s website.About Catalyst BiosciencesCatalyst is a research and clinical development biopharmaceutical company focused on addressing unmet needs in rare hematologic and complement-mediated disorders. Our protease engineering...

SAN DIEGO, Sept. 25, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security Solutions provider, announced today that it has been awarded a $950,000,000 ceiling indefinite-delivery/indefinite-quantity contract for the maturation, demonstration and proliferation of capability across platforms and domains, leveraging open systems design, modern software and algorithm development in order to enable Joint All Domain Command and Control (JADC2). This contract is part of a multiple award multi-level security effort to provide development and operation of systems as a unified force across all domains (air, land, sea, space, cyber, and electromagnetic spectrum) in an open architecture family of systems that enables capabilities via multiple integrated platforms.Kratos offers solutions...

Rogers unveils investments to honour Cogeco’s legacy, expand rural connectivity, accelerate 5G coverage to 95% of Quebecers and create hundreds of highly skilled jobs with new tech innovation hubMONTREAL and TORONTO, Sept. 25, 2020 (GLOBE NEWSWIRE) — After 35 years of building in Quebec, Rogers today unveiled a $3 billion investment proposal to bring connectivity, jobs and economic growth to Quebec should it be successful in its bid to acquire Cogeco’s Canadian assets.“Rogers is deeply committed to the future of innovation and the knowledge economy in Quebec. We would be honoured to help enhance the customer experience and bring new investments including 5G that will fundamentally reshape the economic landscape of Quebec,” said Joe Natale, President and CEO, Rogers Communications. “This is about the future, and helping ensure that...

India’s first Regional Rapid Transit System (RRTS) will operate one of the fastest trains in India with a design speed of 180 kilometers per hour reducing travel time between Meerut and Delhi to less than 60 minutesSleek modern train design is inspired by Delhi’s iconic monument The Lotus TempleBERLIN, Sept. 25, 2020 (GLOBE NEWSWIRE) —Note to editors: To view the photo and the PDF document associated with this press release, please visit the following links:Today, global mobility technology leader Bombardier Transportation and India’s National Capital Region Transport Corporation (NCRTC) celebrated the unveiling of train design for India’s first Regional Rapid Transit System (RRTS). The train design was unveiled by Durga Shanker Mishra, Secretary, Ministry of Housing and Urban Affairs, Government of India in the presence of Vinay...

NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an implementation and equipment financing partnership with AID Genomics, a multi-national genomic R&D company and solution provider focusing on precision medicines for cancers and infectious diseases. AID Genomics recently completed a contract with the Ministry of Health in Israel to build and scale-up 6 HMO laboratories in Israel. In addition, AID Genomics has entered into a worldwide partnership with Tecan Group for delivery of liquid handler machines....

NEW YORK, Sept. 25, 2020 (GLOBE NEWSWIRE) — Logiq, Inc. (formerly Weyland Tech) (OTCQX: WEYL) (OTCQX:LGIQ), a global provider of award-winning eCommerce solutions, has received notification from the Financial Industry Regulatory Authority (FINRA) that its new name, Logiq, Inc., would take effect on the over-the-counter market on September 25, 2020. At the open of trading today, on September 25, 2020, the company commenced trading of its common stock under the new name, Logiq, Inc., and its ticker symbol changed from “WEYL” to “LGIQ.”“Our new name and ticker reflects our evolution from operating primarily as a mCommerce services company to becoming a leading innovator of data-driven consumer intelligence and marketing technology,” said Logiq CEO, Tom Furukawa. “We’ve now entered a new stage of accelerated growth and development.”Over...

LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the independent Data Safety Monitoring Board (DSMB) overseeing the Phase I/II clinical trial of AMT-130 for the treatment of Huntington’s disease has met and reviewed 90-day safety data from the first two patients enrolled in the trial. No significant safety concerns were noted to prevent further dosing, and the next two patients are now cleared for enrollment in the study. The Phase I/II study is a double-blind, randomized clinical trial being conducted in the United States. One patient has been treated with AMT-130, and one patient received the imitation surgery.“We are very pleased with the positive outcome...

LAS VEGAS and VANCOUVER, British Columbia, Sept. 25, 2020 (GLOBE NEWSWIRE) — TAAT LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “Taat”) reports that OTC Markets Group Inc. (“OTCM”), operator of financial markets for 10,000 U.S. and global securities, today announced that the Company has officially “uplisted” from the Pink® market to the OTCQB® exchange (“OTCQB”). In a press release dated July 22, 2020 in which the Company announced it changed its ticker symbol on the Pink® market to TOBAF, the Company also stated it was in the process of applying to uplist to OTCQB. Companies listed on OTCQB must meet high financial standards, and are subject to stringent standards of corporate governance and compliance with securities laws. Taat’s listing on OTCQB provides investors the opportunity...

ALACHUA, Fla., Sept. 25, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Karen Zaderej, chairman, CEO, and president, will present at the JMP Securities MedTech Bio Summit. Axogen’s presentation during this virtual summit is scheduled for Thursday, October 1, 2020 at 11:00 a.m. ET.The presentation will be webcast live and can be accessed through the Investors page at www.axogeninc.com. For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.axogeninc.com.About AxogenAxogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral...

PHILADELPHIA, Sept. 25, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that management will participate in two upcoming virtual investor conferences:Jefferies 2020 Virtual Gene Therapy/Editing SummitFormat: PresentationDate: Friday, October 2, 2020Time: 11 a.m. ETChardan 4thAnnual Genetic Medicines ConferenceFormat: Fireside ChatDate: Monday, October 5, 2020Time: 1 p.m. ETLive audio webcasts of the presentation and fireside chat will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the webcasts will be available for 30 days following the presentation and fireside chat.About Passage BioPassage Bio is a genetic...